{{Rsnum
|rsid=7204609
|Gene=FTO
|Chromosome=16
|position=53799693
|Orientation=plus
|GMAF=0.2282
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=FTO
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 2.7 | 97.3
| HCB | 13.1 | 54.7 | 32.1
| JPT | 15.9 | 52.2 | 31.9
| YRI | 19.0 | 47.6 | 33.3
| ASW | 19.3 | 40.4 | 40.4
| CHB | 13.1 | 54.7 | 32.1
| CHD | 13.8 | 47.7 | 38.5
| GIH | 1.0 | 13.9 | 85.1
| LWK | 24.5 | 41.8 | 33.6
| MEX | 1.7 | 24.1 | 74.1
| MKK | 14.7 | 49.4 | 35.9
| TSI | 0.0 | 4.9 | 95.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=21741858
|Title=The rs7204609 Polymorphism in the Fat Mass and Obesity-Associated Gene is Positively Associated With Central Obesity and Microalbuminuria in Patients With Type 2 Diabetes From Southern Brazil
}}

{{PMID|18379722|OA=1
}} Variations in the FTO gene are associated with severe obesity in the Japanese.

{{PMID|19265514|OA=1
}} FTO gene variation and measures of body mass in an African population.

{{PMID|19322589|OA=1
}} Analysis of FTO gene variants with measures of obesity and glucose homeostasis in the IRAS Family Study.

{{PMID|19912668|OA=1
}} Design and evaluation of a treatment programme for Spanish adolescents with overweight and obesity. The EVASYON Study.

{{PMID|20299471|OA=1
}} FTO genetic variation and association with obesity in West Africans and African Americans.

{{PMID|22384102|OA=1
}} A latent variable partial least squares path modeling approach to regional association and polygenic effect with applications to a human obesity study.

{{PMID Auto
|PMID=23771786
|Title=Genetic variants in the fat mass- and obesity-associated (FTO) gene are associated with alcohol dependence.
}}

{{on chip | Illumina Human 1M}}